ARCHIVES

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

This article is from The Cancer Letter archive.

Vol. 34 No. 25 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979

Remaining DCT Recompetitions

November 7, 1980

Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House

April 3, 1998

Latest State Cancer Statistics Released.

January 14, 2005